-transparent.png){kind=logo}
OBJECTIVE Urocortin is a recently identified neuropeptide of the corticotrophin-releasing factor (CRF) family in the mammalian brain and has been demonstrated to stimulate ACTH secretion from pituitary cells, but its expression in human brain tissue including the hypothalamus has not been examined. In this study, we first examined urocortin expression in the hypothalamus (20 cases) and pituitary stalks (17 cases) of human brain obtained from autopsy using immunohistochemistry and mRNA in situ hybridization. RESULTS Neither urocortin immunoreactivity nor mRNA hybridization signals were detected in the hypothalami and pituitary stalks while CRF immunoreactivity was detected in the paraventricular nuclei of the hypothalami in 10/20 cases and in nerve fibres of the stalks in 17/17 cases. These results indicate that urocortin does not act on the hypothalamo-pituitary-adrenal axis, at least not in the same manner as CRF in humans. We then examined urocortin expression in various portions of the brain in 7 cases. Both urocortin immunoreactivity and mRNA hybridization were detected in Purkinje cells of the cerebellum and anterior horn cells of the spinal cord in specimens examined. Urocortin expression was, however, variably seen in superior olivary nuclei (two out of six cases examined) and in the Edingar-Westphal nuclei (one out of three cases examined). CONCLUSIONS The distribution of urocortin in the human central nervous system suggests that urocortin may work as a neurotransmitter like other neuropeptides in the human.
K Iino, and
H Sasano, and
Y Oki, and
N Andoh, and
R W Shin, and
T Kitamoto, and
K Takahashi, and
H Suzuki, and
F Tezuka, and
T Yoshimi, and
H Nagura
September 2021,
Biology,
K Iino, and
H Sasano, and
Y Oki, and
N Andoh, and
R W Shin, and
T Kitamoto, and
K Takahashi, and
H Suzuki, and
F Tezuka, and
T Yoshimi, and
H Nagura
February 1998,
The Journal of comparative neurology,
K Iino, and
H Sasano, and
Y Oki, and
N Andoh, and
R W Shin, and
T Kitamoto, and
K Takahashi, and
H Suzuki, and
F Tezuka, and
T Yoshimi, and
H Nagura
April 2001,
Neuropathology and applied neurobiology,
K Iino, and
H Sasano, and
Y Oki, and
N Andoh, and
R W Shin, and
T Kitamoto, and
K Takahashi, and
H Suzuki, and
F Tezuka, and
T Yoshimi, and
H Nagura
July 2003,
Brain research. Developmental brain research,
K Iino, and
H Sasano, and
Y Oki, and
N Andoh, and
R W Shin, and
T Kitamoto, and
K Takahashi, and
H Suzuki, and
F Tezuka, and
T Yoshimi, and
H Nagura
December 2004,
Free radical biology & medicine,
K Iino, and
H Sasano, and
Y Oki, and
N Andoh, and
R W Shin, and
T Kitamoto, and
K Takahashi, and
H Suzuki, and
F Tezuka, and
T Yoshimi, and
H Nagura
November 2002,
The Journal of comparative neurology,
K Iino, and
H Sasano, and
Y Oki, and
N Andoh, and
R W Shin, and
T Kitamoto, and
K Takahashi, and
H Suzuki, and
F Tezuka, and
T Yoshimi, and
H Nagura
November 2005,
Brain research. Developmental brain research,
K Iino, and
H Sasano, and
Y Oki, and
N Andoh, and
R W Shin, and
T Kitamoto, and
K Takahashi, and
H Suzuki, and
F Tezuka, and
T Yoshimi, and
H Nagura
July 1996,
Cancer research,
K Iino, and
H Sasano, and
Y Oki, and
N Andoh, and
R W Shin, and
T Kitamoto, and
K Takahashi, and
H Suzuki, and
F Tezuka, and
T Yoshimi, and
H Nagura
July 1990,
The Journal of clinical investigation,
K Iino, and
H Sasano, and
Y Oki, and
N Andoh, and
R W Shin, and
T Kitamoto, and
K Takahashi, and
H Suzuki, and
F Tezuka, and
T Yoshimi, and
H Nagura
March 1998,
Clinical endocrinology,
